← Back to Search
Successful Adenovirus-mediated Gene Transfer In An In Vivo Model Of Human Malignant Mesothelioma.
W. Smythe, L. Kaiser, H. Hwang, K. Amin, J. Pilewski, S. Eck, J. Wilson, S. Albelda
Published 1994 · Medicine
Download PDFAnalyze on Scholarcy
Malignant mesothelioma remains a frustrating clinical problem with uniformly poor responses to current therapeutic regimens. However, the localized nature of the disease, the potential accessibility of the tumor, and the relative lack of distant metastases make it a particularly attractive candidate for somatic gene therapy. The purpose of this study was to evaluate the ability of an adenoviral vector system to transfer genetic material to human mesothelioma cells in vitro and in vivo. Using a replication-deficient recombinant adenovirus carrying the Escherichia coli lacZ marker gene, we found that human mesothelioma cell lines were susceptible to adenovirus infection. Furthermore, surprisingly effective gene transfer was accomplished within tumor implants of human mesothelioma growing within the peritoneal cavity of immunodeficient mice after intraperitoneal administration of virus. These studies demonstrate that adenoviral vectors hold promise as vehicles to deliver gene therapy in human malignant mesothelioma.
This paper references
Multiple transduction as a means of preserving ganciclovir chemosensitivity in sarcoma cells carrying retrovirally transduced herpes thymidine kinase genes.
F. S. Moolten (1992)
Quantitative comparison between the transplantability of human and murine tumors into the subcutaneous tissue of NCr/Sed-nu/nu nude and severe combined immunodeficient mice.
A. Taghian (1993)
Gene therapy: adenovirus vectors.
K. Kozarsky (1993)
The role of extrapleural pneumonectomy in malignant pleural mesothelioma. A Lung Cancer Study Group trial.
V. Rusch (1991)
Direct gene transfer of human CFTR into human bronchial epithelia of xenografts with E1–deleted adenoviruses
J. Engelhardt (1993)
Protection of human endothelial cells from oxidant injury by adenovirus-mediated transfer of the human catalase cDNA.
S. Erzurum (1993)
Characterization of a human malignant mesothelioma cell line (H-MESO-1): a biphasic solid and ascitic tumor model.
Frank R. Reale (1987)
Interactions of cancer cells with the microvasculature during metastasis 1 2
L. Weiss (1988)
The Wilms tumour gene WT1 is expressed in murine mesoderm–derived tissues and mutated in a human mesothelioma
S. Park (1993)
The epidemiology and pathogenesis of malignant mesothelioma.
J. Craighead (1989)
In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats.
Z. Ram (1993)
Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors.
F. Moolten (1990)
Control of respiratory disease in recruits with types 4 and 7 adenovirus vaccines.
F. Top (1971)
Development of adenovirus vectors for the expression of heterologous genes.
Berkner Kl (1988)
The basic science of gene therapy.
R. Mulligan (1993)
Extrapleural pneumonectomy, chemotherapy, and radiotherapy in the treatment of diffuse malignant pleural mesothelioma.
D. Sugarbaker (1991)
This paper is referenced by
Antitumor efficacy of regional oncolytic viral therapy for peritoneally disseminated cancer
J. Bennett (2000)
Adenovirus cancer gene therapy
M. Powell (2001)
The evaluation of adenoviral p53-mediated bystander effect in gene therapy of cancer
N. Rizk (1999)
Gene therapy in pleural diseases
S. Albelda (2008)
CSPG4 as a Target of Antibody-Based Immunotherapy for Malignant Mesothelioma
Z. Rivera (2012)
Adenovirus-mediated gene therapy of ovarian cancer in a mouse model.
K. Behbakht (1996)
Analysis of Gene Expression in 3D Spheroids Highlights a Survival Role for ASS1 in Mesothelioma
D. Barbone (2016)
CHAPTER 32 – Treatment of Mesothelioma Using Adenoviral-Mediated Delivery of Herpes Simplex Virus Thymidine Kinase Gene in Combination with Ganciclovir
D. Sterman (2002)
Treatment of pleural mesothelioma in an immunocompetent rat model utilizing adenoviral transfer of the herpes simplex virus thymidine kinase gene.
A. Elshami (1996)
Cardiac gene transfer by intracoronary infusion of adenovirus vector-mediated reporter gene in the transplanted mouse heart.
J. Lee (1996)
Vorinostat Eliminates Multicellular Resistance of Mesothelioma 3D Spheroids via Restoration of Noxa Expression
D. Barbone (2012)
GENE THERAPY AND OVARIAN CANCER: A REVIEW
M. Barnes (1997)
Adenovirus-mediated gene transfer of herpes simplex virus thymidine kinase in an ascites model of human breast cancer.
D. Yee (1996)
ZIC1 Is Silenced and Has Tumor Suppressor Function in Malignant Pleural Mesothelioma
Y. Cheng (2013)
Single-Dose Intrapleural IFN-B GeneTransfer forMalignant PleuralMesotheliomaandMetastatic Pleural Effusions : HighRate ofAntitumor ImmuneResponses
D. Sterman (2007)
Immuno-gene therapy with interferon-beta before surgical debulking delays recurrence and improves survival in a murine model of malignant mesothelioma.
Robert J Kruklitis (2004)
Genetic Modification of the Lung Directed Toward Treatment of Human Disease.
D. Sondhi (2017)
Treatment of advanced mesothelioma with the recombinant adenovirus H5.010RSVTK: a phase 1 trial (BB-IND 6274).
J. Treat (1996)
Advances in the treatment of malignant pleural mesothelioma.
D. Sterman (1999)
Estrogen receptor β activation impairs mitochondrial oxidative metabolism and affects malignant mesothelioma cell growth in vitro and in vivo
A. G. Manente (2013)
Adenovirus-mediated gene transfer of enhanced Herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killing
R. Wiewrodt (2003)
Gene therapy for thoracic disease: practice, promise, and pragmatism.
W. Smythe (2002)
BAK and NOXA Are Critical Determinants of Mitochondrial Apoptosis Induced by Bortezomib in Mesothelioma
S. Busacca (2013)
Long-term survival of immunocompetent rats with intraperitoneal colon carcinoma tumors using herpes simplex thymidine kinase/ganciclovir and IL-2 treatments
J.-L. Coll (1997)
Gene therapy of mesothelioma
D. Nelson (2005)
Human adenovirus vectors for gene transfer into mammalian cells.
M. M. Hitt (1997)
Pleurectomy/decortication for palliation in malignant pleural mesothelioma: results of surgery.
O. Soysal (1997)
A Phase I Clinical Trial of Single-Dose Intrapleural IFN-β Gene Transfer for Malignant Pleural Mesothelioma and Metastatic Pleural Effusions: High Rate of Antitumor Immune Responses
D. Sterman (2007)
HSV-1 thymidine kinase gene therapy for colorectal adenocarcinoma-derived peritoneal carcinomatosis
C. Lechanteur (1997)
Adenoviral-mediated delivery of the herpes simplex virus thymidine kinase gene selectively sensitizes human ovarian carcinoma cells to ganciclovir.
M. E. Rosenfeld (1995)
Cancer Therapy : Preclinical CSPG 4 as a Target of Antibody-Based Immunotherapy for Malignant Mesothelioma
Zeyana Rivera (2012)
A Polysome-Based microRNA Screen Identifies miR-24-3p as a Novel Promigratory miRNA in Mesothelioma.
Stefania Oliveto (2018)See more